The autocrine secretion of IL-6 by tumor cells is also confirmed to contribute to chemo-resistance; further studies demonstrated that drug sensitive tumor cells do not or low express IL-6, yet, multidrug resistant breast cancer cells secreted more IL-6 [31]. This evidence concerns the gene IL6 and breast carcinoma.